| Host: |
HEK293 cells |
| Reactivity: |
SARS-COV-2 |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-SARS-COV-2 Spike RBD (Lambda/C.37)-C-His protein was developed from hek293 cells and has a target region of C-His. For use in research applications. |
| Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Immunoreactivity: |
Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2 Spike RBD (Lambda/C.37) at 2 Mu g/mL (100 Mu L/well) can bind Human ACE2 (Catalog: RP01275) with a linear range of 0.1-6.35 ng/mL. |
| Immunogen Region: |
F490S, L452Q |
| Immunogen: |
Recombinant SARS-COV-2 Spike RBD (Lambda/C.37) Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Arg319-Phe541 (F490S, L452Q) ) of sars-cov-2 Spike RBD (F490S, L452Q) (Accession #YP_009724390.1) fus |
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
